California's AB 824 law has important implications for branded and generics companies involved in settlement agreements. AB ...

On this week's Business of Biotech, Michelle Werner, CEO at Alltrna, talks transfer RNA (tRNA) therapy with host Ben Comer and guest co-host Anna Rose Welch, editorial and community director at ...

Improvements in diagnostics for the early detection of Alzheimer's disease have the potential to transform patient care and ...

For small pharmas and biotechs approaching a commercial launch, agility and execution are more valuable than waiting for a ...

In a follow up to his recent appearance on the Business of Biotech, Tolga Tanguler explains how Alnylam is positioning ...

FUJIFILM Diosynth Biotechnologies, a leading global contract development and manufacturing organization (CDMO) with a significant presence in North Carolina, has entered into a landmark agreement with ...

On this week's episode of the Business of Biotech, Dr. Mark Eisner, EVP and Chief Medical Officer at Vir Biotechnology, talks about the company's post-COVID pivot into infectious diseases (Hepatitis ...

Genentech, widely regarded as one of the founding companies of the biotechnology industry, has announced plans to establish a major new manufacturing presence in Holly Springs, North Carolina. The ...

The Piedmont Triad Regenerative Medicine Engine (PTRME) hosted its inaugural large-scale workshop, The Founders’ Journey, on April 14 and 15. This two-day event was designed to empower and support ...